Analyze Diet

Topic:Sarcoids

Sarcoids are a type of skin tumor commonly found in horses, characterized by their locally aggressive behavior but non-metastatic nature. These tumors are associated with bovine papillomavirus infection and can appear in various forms, including nodular, verrucous, and fibroblastic types. Sarcoids are the most frequently diagnosed equine skin tumors and can affect horses of any age, breed, or sex. They often occur on the head, limbs, and ventral abdomen, causing discomfort and potential interference with tack and equipment. This page compiles peer-reviewed research studies and scholarly articles that investigate the etiology, pathology, clinical presentation, and management strategies for equine sarcoids.
Spontaneous regression of equine sarcoids is an exceptional event.
Equine veterinary journal    March 11, 2026   doi: 10.1002/evj.70158
Brandt S.Sarcoids are benign, yet locally aggressive skin tumours that commonly affect horses and other equid species. The lesions are induced by bovine papillomavirus types 1, 2, and probably 13 in conjunction with other factors including trauma and a genetic predisposition. Although sarcoids have a substantial impact on the health and welfare of affected equids, information on the immune response to bovine papillomavirus infection and resulting sarcoids is limited. However, there is evidence that sarcoid disease is associated with an impaired immune response to bovine papillomavirus infection. This o...
Cannabidiol-induced cellular and matrix-associated responses in primary equine sarcoid cells.
Journal of veterinary internal medicine    February 26, 2026   Volume 40, Issue 1 aalaf015 doi: 10.1093/jvimsj/aalaf015
Semik-Gurgul E, Ocłoń E, Zubel-Łojek J, Pędziwiatr R, Pawlina-Tyszko K.Sarcoids are locally invasive skin tumors in equids, associated with bovine papillomavirus. Objective: Address potential applications of cannabidiol (CBD) in veterinary medicine. We evaluated the response of equine sarcoid cells to CBD in vitro, focusing on viability, invasiveness, and matrix remodeling. Methods: Three primary sarcoid cell lines. Methods: Cells were treated with CBD (20, 6.75, 2.25, 0.75 μM) and incubated for 6, 24, 48, 72 hours. Cell viability, cytotoxicity, and apoptosis were assessed using the ApoTox-Glo Assay. Based on these results, further analyses were performed for ...
Engineered biopolymeric hydrogels for in vitro modeling of equine sarcoid tumors in comparative oncology.
International journal of biological macromolecules    February 9, 2026   Volume 348 150840 doi: 10.1016/j.ijbiomac.2026.150840
Zanacchi A, Fruscione F, Grasselli S, Razzuoli E, Pastorino L, Di Lisa D.Developing advanced preclinical in vitro cancer models is essential for understanding tumor biology, improving drug discovery, and enhancing the clinical translation of new therapies. Papillomaviruses (PVs) cause diverse lesions in humans and animals; notably, bovine papillomavirus (BPV) is the main cause of equine sarcoid, the most common skin tumor in horses. Its pathogenesis involves viral infection, fibroblast transformation, and extracellular matrix (ECM) remodeling. These processes highlight the limitations of conventional two-dimensional (2D) culture systems, which fail to replicate the...
Selected microRNAs as biomarkers in sarcoid-affected horses under immunotherapy with a mistletoe extract. Beermann A, Hamza E, Reinhard S, Koch C, Oberhänsli T, Unger L.We investigated microRNAs (miRNAs) as potential prognostic biomarkers for equine sarcoid (ES) disease. In a breed-, age-, and sex-matched case-controlled study involving 45 ES-affected and 15 control horses, we assessed the diagnostic, prognostic, and theragnostic value of 3 miRNAs (eca-miR-127, eca-miR-379, eca-miR-432) in horses treated with European mistletoe () extract versus placebo. Whole-blood miRNA concentrations were measured using reverse-transcription quantitative real-time PCR (RT-qPCR) at 3 different times. We found that eca-miR-432 expression was lower in ES-affected (median =...
Equine Sarcoid Arising From the Medial Caruncle With Invasion of the Third Eyelid in a Quarter Horse Gelding.
Veterinary ophthalmology    September 4, 2025   Volume 29, Issue 2 e70074 doi: 10.1111/vop.70074
Plotsker NM, Taylor R, Coffin HR, Beatty A, Newbold G, Knickelbein KE.To describe the clinical and histologic features of a sarcoid arising from the medial caruncle with spread to the third eyelid of a horse. Methods: A 20-year-old Quarter Horse gelding. Methods: An incisional biopsy of the medial caruncle mass was initially performed, with histopathology suggesting a sarcoid or other spindle cell neoplasm. The mass grew rapidly following the biopsy, expanding to affect the third eyelid and adjacent superior palpebral conjunctiva. A complete third eyelid and medial caruncle excision with resection of affected palpebral conjunctiva and adjunctive cryotherapy was ...
Accurate identification of bovine deltapapillomavirus in equine sarcoids by ddPCR.
Scientific reports    August 11, 2025   Volume 15, Issue 1 29414 doi: 10.1038/s41598-025-15353-6
Cutarelli A, Buonavoglia A, Fusco G, Pellicanò R, Napoletano M, Brandt S, Roperto S.Sarcoids are benign and locally aggressive skin lesions that commonly affect horses and other equid species. Sarcoids are generally considered to be caused by bovine delta-papillomaviruses (δPVs) types 1 and 2 (BPV1 and BPV2, respectively). Moreover, while bovine δPV types 13 and 14 (BPV13 and BPV14, respectively) are also suspected to induce sarcoids, information regarding this possibility and the occurrence of multiple bovine δPV infections in sarcoids is scarce. This study aimed, for the first time, to assess BPV1, BPV2, BPV13, and BPV14 infections and co-infections in equine sarcoid sam...
Neoplastic and non-neoplastic swellings of the external genitalia in horses and donkeys: clinical, histopathological, and treatment outcomes.
Frontiers in veterinary science    August 5, 2025   Volume 12 1613601 doi: 10.3389/fvets.2025.1613601
El-Shafaey ES, Hamed M, Amin Y, Alkhodair KM, Shousha S, Aljazzar A, El Sebaei MG, Mosbah E.External genitalia swellings represent diagnostic and treatment challenges in equids. Thus, the present study aimed to describe the clinical, histopathological, and treatment outcomes of external genitalia swellings in horses and donkeys. Unassigned: Seventy-five equids (49 horses and 26 donkeys) from 6 months to 8 years were enrolled based on the clinical evidence of external genital swellings. The descriptive details, including sex, age, lesion location, and treatment outcomes, for each case were recorded and analyzed. Unassigned: Twenty forms of external genital swellings were recorded ...
Equine Veterinarian Perspectives on Mucocutaneous Tumors in Horses: A Survey-Based Study in Portugal.
Animals : an open access journal from MDPI    June 23, 2025   Volume 15, Issue 13 1853 doi: 10.3390/ani15131853
Pimenta J, Cotovio M.This study explores equine veterinarians' clinical practices regarding mucocutaneous tumors, based on a survey conducted among members of the Portuguese Association of Equine Veterinarians, and examines their perceptions of owner and buyer concerns regarding these tumors. Veterinarians expressed significantly greater concern about squamous cell carcinoma (SCC) during routine examinations ( < 0.001) compared to sarcoids and melanomas. Concern over sarcoids was significantly greater during pre-purchase evaluations compared to routine clinical exams ( = 0.03). For melanomas, a trend toward increa...
Genetic susceptibility to sarcoid in Arabian horses: associations with MHC class II and compound MHC class I/KLRA genotypes.
Veterinary research communications    May 1, 2025   Volume 49, Issue 3 184 doi: 10.1007/s11259-025-10748-2
Vychodilova L, Plasil M, Futas J, Kopecka A, Molinkova D, Wijacki T, Jahn P, Knoll A, Horin P.Although the Major Histocompatibility Complex (MHC) has been repeatedly associated with susceptibility to equine sarcoid, a disease associated with bovine papillomavirus infection, the role of the MHC in the mechanisms of the disease is not fully understood. The objectives of our work were to analyze associations between polymorphic markers of the MHC genomic subregions and of the Natural Killer Complex (NKC) genomic region and the presence of sarcoid in Arabian horses. Microsatellite loci located in the MHC class I, II and III subregions and two MHC class II genes (DRA, DQA1), along with a se...
Altered expression of collagen gene family members and its epigenetic background in equine Sarcoids.
Research in veterinary science    April 21, 2025   Volume 190 105656 doi: 10.1016/j.rvsc.2025.105656
Pawlina-Tyszko K, Semik-Gurgul E, Podstawski P, Herc W, Witkowski M, Ropka-Molik K.Alterations in the genes involved in the creation of the extracellular matrix (ECM) were observed in our earlier transcriptome studies of sarcoids and their cell culture model. For a complete characterization of the underlying molecular pathways, it is imperative to comprehend the involvement of ECM modifications in the oncogenic transformation of sarcoid fibroblasts. Thus, the aim of this investigation was to describe the expression patterns of a set of genes that are essential for the rearrangements of the extracellular matrix, namely collagen genes, and elucidate possible mechanisms underly...
Safety and immunogenicity of a sarcoid vaccine in horses.
Journal of equine veterinary science    February 10, 2025   Volume 146 105381 doi: 10.1016/j.jevs.2025.105381
Jacob O, Hause B, Peters-Smith K, Adam EN, Page AE, Floyd C, Tucker C, Eertink LG, Wang D, Li F.Equine sarcoids are the most identified skin tumors of horses, which are highly associated with bovine papillomavirus infection. Sarcoids can impair the use of the horse and are difficult to treat, resulting in significant economic losses and a welfare concern. There is no vaccine available to protect global equines from sarcoids. We aimed to determine the safety and protective antibody response in horses immunized with a recombinant baculovirus vector vaccine expressing the L1 protein of bovine papillomavirus type 1 (BPV1). A group of 10 clinically healthy, sarcoid-free horses were immunized ...
Molecular Characterization of Bovine Deltapapillomavirus in Equine Sarcoids in Egypt.
Veterinary medicine international    January 3, 2025   Volume 2025 9773642 doi: 10.1155/vmi/9773642
Sobhy NM, Refaai W, Kumar R, Bottros Youssef CR, Goyal SM.Bovine papillomaviruses (BPVs) commonly cause sarcoids in equines worldwide. Equine sarcoids (ESs) reduce the working ability of draft animals and produce untoward cosmetic changes in racing and dancing equine. In this study, nine horses and 16 donkeys with sarcoids were presented to Zagazig University Veterinary Clinic, Zagazig, Egypt. Of these, eight horses and six donkeys were found to be infected with BPV. On sequencing, all 14 viruses were found to be BPV1, which were distributed in two clades without specific differentiation among papillomaviruses (PVs) of donkeys, horses, and cattle. Co...
What Is the Evidence Behind Sarcoid Treatments?
The Veterinary clinics of North America. Equine practice    August 24, 2024   Volume 40, Issue 3 409-419 doi: 10.1016/j.cveq.2024.07.006
Hollis AR.Despite the ubiquitous nature of sarcoids, robust data regarding the selection of treatment modalities are scarce, with many treatments having little or no published data to support their use. Treatment options are numerous and vary with the location and type of sarcoid, treatment accessibility, and the financial status of the owner. Many treatments are expensive and time-consuming, and some have health and safety implications. It is this author's belief that, based on the limited evidence base, appropriate treatment options vary with the location and type of the sarcoid, and no one treatment ...
Radiotherapy in Equine Practice.
The Veterinary clinics of North America. Equine practice    August 20, 2024   S0749-0739(24)00054-3 doi: 10.1016/j.cveq.2024.07.005
Mudge MC, Green E.Radiotherapy is a valuable treatment option for equine tumors that have a high rate of recurrence or where complete surgical resection may damage vital structures. Teletherapy, brachytherapy, and plesiotherapy have been used successfully for the treatment of a variety of tumors and locations in the horse. Radiobiology, treatment protocols, side effects, and patient management are reviewed, with a focus on linear accelerator-based teletherapy. There is evidence of good success rates for treatment of periocular sarcoids and squamous cell carcinoma but teletherapy treatment is often limited to tu...
DNA Methylation and Its Effects on TRIM29 Gene Expression in the Equine Sarcoid Tissue.
Veterinary and comparative oncology    July 10, 2024   doi: 10.1111/vco.12994
Ewelina SG, Anna Z, Rafał P, Maciej W.Sarcoids are the most frequently diagnosed dermatological tumour in horses. It is a disease that can affect various species of equids, such as donkeys, mules and zebras. This type of tumour can develop in all horse breeds, regardless of age and gender. Treatment options depend on many factors, such as the type of lesion, location, extent, owner preference and financial considerations. In the present study, we investigated the TRIM29 expression, the methylation status of its first exon and its involvement in the formation of equine sarcoids. Bisulfite sequencing PCR (BSP) was used to determine ...
Programmed-cell death ligand 1 (PD-L1) expression in equine sarcoids and squamous cell carcinoma.
Open veterinary journal    June 30, 2024   Volume 14, Issue 6 1476-1482 doi: 10.5455/OVJ.2024.v14.i6.16
Pimenta J, Prada J, Pires I, Cotovio M.Sarcoids and squamous cell carcinomas (SCCs) are the most concerning equine oncological diseases. Both tumors are challenging to manage due to their invasive behavior and high prevalence of recurrences. Furthermore, SCCs have a propensity to metastasize. Programed cell-death ligand 1 (PD-L1) has been one of the main therapeutic targets for immunotherapy in various human tumors. PD-L1 research in equine tumors is scarce and more efforts are necessary to understand the potential of this biomarker as a therapeutical target. Unassigned: Evaluate the immunohistochemical expression of PD-L1 in equin...
A randomized placebo-controlled double-blinded study comparing oral and subcutaneous administration of mistletoe extract for the treatment of equine sarcoid disease.
Journal of veterinary internal medicine    March 26, 2024   doi: 10.1111/jvim.17052
Beermann A, Clottu O, Reif M, Biegel U, Unger L, Koch C.Equine sarcoids (ES) are the most common cutaneous tumors in equids. Systemic treatment options are sparse. Subcutaneous (SC) injections of Viscum album extract (VAE) demonstrate efficacy as a systemic treatment directed against ES. Objective: To critically assess the therapeutic efficacy of orally administered VAE. Methods: Forty-five ES-affected, privately owned, 3-12 year-old horses. Methods: A 3-armed randomized placebo-controlled, double-blinded study was conducted in a double-dummy design. Horses were subjected to oral administration and SC injections of either VAE or placebo (VAE oral...
Sarcoid within the oral cavity of a horse.
Journal of equine veterinary science    January 13, 2024   105003 doi: 10.1016/j.jevs.2024.105003
Munday JS, Lewis MC, Leyland MH.Equine sarcoids are common skin tumors that are thought to be caused by cross-species infection by bovine papillomaviruses (BPV). A 16-year-old horse developed a 1cm diameter mandibular gingival mass opposite the right second premolar tooth (406) and a 2cm diameter mass close to the commissure of the lips on the same side of the mouth. The right cheek was diffusely thickened. Histology of the smaller mass revealed a proliferation of mesenchymal cells covered by hyperplastic epithelium that formed thick rete pegs. BPV2 DNA was amplified from the mass. Although the mass had been incompletely exc...
Longitudinal pilot study examining the effect of punch biopsy on equine sarcoid growth dynamics.
Veterinary dermatology    January 2, 2024   doi: 10.1111/vde.13236
Gysens L, Martens A, Haspeslagh M.Nonexcisional tissue biopsies facilitate pre-operative confirmation of equine sarcoid yet fear of lesion deterioration currently limits its use in the diagnostic workup. Objective: To evaluate the effect of a single punch biopsy on tumour growth dynamics [thickness, area, circumference, viral load (VL) and Visual Analog Scale (VAS)]. Methods: Six client-owned horses with 11 sarcoids of various classification. Methods: Growth dynamics were recorded on a weekly basis, 12 weeks pre- and 24 weeks post-biopsy. The effect of a single punch biopsy on growth dynamics was estimated by linear mixed-...
Equine sarcoids: A clinicopathologic study of 49 cases, with mitotic count and clinical type predictive of recurrence.
Veterinary pathology    November 8, 2023   3009858231209408 doi: 10.1177/03009858231209408
Karalus W, Subharat S, Orbell G, Vaatstra B, Munday JS.Sarcoids are common mesenchymal neoplasms of horses. Although there are few studies in which sarcoids have been followed over a long period of time, sarcoids are considered locally invasive and have been reported to frequently recur following surgical excision. Currently, no histological features have been identified to predict which sarcoids will recur after excision. The present study comprised 49 sarcoids for which histology sections were available and in which the recurrence status of the case was known. Each sarcoid was excised from a different horse. Overall, 12 of the 49 (24%) sarcoids ...
CRISPR/Cas9-Mediated Targeting of BPV-1-Transformed Primary Equine Sarcoid Fibroblasts.
Viruses    September 17, 2023   Volume 15, Issue 9 1942 doi: 10.3390/v15091942
Monod A, Koch C, Jindra C, Haspeslagh M, Howald D, Wenker C, Gerber V, Rottenberg S, Hahn K.Equine sarcoids (EqS) are fibroblast-derived skin tumors associated with bovine papillomavirus 1 and 2 (BPV-1 and -2). Based on Southern blotting, the BPV-1 genome was not found to be integrated in the host cell genome, suggesting that EqS pathogenesis does not result from insertional mutagenesis. Hence, CRISPR/Cas9 implies an interesting tool for selectively targeting BPV-1 episomes or genetically anchored suspected host factors. To address this in a proof-of-concept study, we confirmed the exclusive episomal persistence of BPV-1 in EqS using targeted locus amplification (TLA). To investigate...
Transcriptome and methylome sequencing reveals altered long non-coding RNA genes expression and their aberrant DNA methylation in equine sarcoids.
Functional & integrative genomics    August 8, 2023   Volume 23, Issue 3 268 doi: 10.1007/s10142-023-01200-2
Semik-Gurgul E, Gurgul A, Szmatoła T.Recent publications confirmed that long non-coding RNAs (lncRNAs) perform an essential function in gene-specific transcription regulation. Nevertheless, despite its important role, lncRNA has not yet been described in equine sarcoids, the skin neoplasia of horses. Therefore, the aim of this study is to deepen the knowledge about lncRNA expression in the pathogenesis of equine sarcoids and provide new insight into the regulatory function of lncRNA in the bovine papillomavirus-dependent neoplasia of horse dermal tissues. RNA sequencing (RNA-seq) data from 12 equine sarcoid samples and the corres...
The serological detection of Bovine papillomavirus’s E5 oncoprotein antibodies in horses.
Veterinary immunology and immunopathology    July 26, 2023   Volume 262 doi: 10.1016/j.vetimm.2023.110633
Hoikhman R, Molinková D, Pillárová D, Linhart P, Kopecká A, Jahn P.Equine sarcoids (ES) are known globally as the most frequent skin tumour affecting horses. These tumours affect the horse's monetary value, they can affect the horse's welfare and can be difficult and expensive to treat. Bovine papillomavirus (BPV) is considered to be the aetiological agent of this tumour, as BPV 1, 2 and 13 have been detected in ES. This is the only known natural cross species infection by a papillomavirus. The BPV genome can be divided into two coding regions: The early region E which encodes the transforming proteins E5, E6 and E7 as well as the replication and transcriptio...
Methylome and transcriptome data integration reveals aberrantly regulated genes in equine sarcoids.
Biochimie    May 19, 2023   Volume 213 100-113 doi: 10.1016/j.biochi.2023.05.008
Semik-Gurgul E, Szmatoła T, Gurgul A, Pawlina-Tyszko K, Gałuszka A, Pędziwiatr R, Witkowski M, Ząbek T.DNA methylation is a key mechanism in transcription regulation, and aberrant methylation is a common and important mechanism in tumor initiation, maintenance, and progression. To find genes that are aberrantly regulated by altered methylation in horse sarcoids, we used reduced representation bisulfite sequencing (RRBS) accompanied by RNA sequencing (RNA-Seq) for methylome (whole genome DNA methylation sequencing) and transcriptome profiling, respectively. We found that the DNA methylation level was generally lower in lesion samples than in controls. In the analyzed samples, a total of 14,692 d...
Performance of fine-needle aspirate testing compared with superficial swab testing for quantification of BPV-1/-2 viral load in equine sarcoids.
Research in veterinary science    April 23, 2023   Volume 159 101-105 doi: 10.1016/j.rvsc.2023.04.014
Gysens L, Martens A, Haspeslagh M.Bovine papillomavirus (BPV) types 1 and 2 are causally associated with equine sarcoid, the most common mesenchymal neoplasm of horses, but the viral load (VL) differs between lesions. Sensitive and accurate BPV detection and quantification is essential for clinicians to confirm clinical suspicion, as well as in research settings for stratifying these skin lesions. Due to the limitations of histopathology in sarcoid diagnosis, PCR screening of superficial swabs constitutes the principal sampling method for BPV detection. This study aimed to investigate the ability of superficial swabs and fine-...
Immunotherapy of Equine Sarcoids-From Early Approaches to Innovative Vaccines.
Vaccines    March 30, 2023   Volume 11, Issue 4 769 doi: 10.3390/vaccines11040769
Jindra C, Hainisch EK, Brandt S.Horses and other equid species are frequently affected by bovine papillomavirus type 1 and/or 2 (BPV1, BPV2)-induced skin tumors termed sarcoids. Although sarcoids do not metastasize, they constitute a serious health problem due to their BPV1/2-mediated resistance to treatment and propensity to recrudesce in a more severe, multiple form following accidental or iatrogenic trauma. This review provides an overview on BPV1/2 infection and associated immune escape in the equid host and presents early and recent immunotherapeutic approaches in sarcoid management.
Treatment of equine sarcoids: A systematic review.
Equine veterinary journal    March 14, 2023   doi: 10.1111/evj.13935
Offer KS, Dixon CE, Sutton DGM.The sarcoid is the most common equine cutaneous neoplasm. Evidence-based treatment of this condition is often lacking, and selection of treatment modality based on clinical experience or anecdotal evidence. Objective: To assess the quality of the currently available best evidence regarding the treatment of the equine sarcoid. Methods: Systematic review. Methods: In compliance with PRISMA guidelines, literature searches were performed in PUBMED, Web of Science, CAB Abstracts, EMBASE (Ovid) and Scopus in April 2021. Included papers were required to describe an interventional study examining sarc...
Histological evidence of superficial inflammation is associated with lower recurrence of equine sarcoids following surgical removal: A follow-up study of 106 tumours in 64 horses.
Veterinary journal (London, England : 1997)    February 11, 2023   Volume 292 105953 doi: 10.1016/j.tvjl.2023.105953
Curnow B, Rich AF, Ireland J, Correa DC, Dunn J, Jenkins D, Carslake H, Ressel L.Although the equine sarcoid is the most common skin neoplasm in domesticated horses, histopathological characteristics have not previously been evaluated for association with recurrence. The aim of this retrospective cohort study was to investigate clinical and histopathological features of excised equine sarcoids and to evaluate their association with recurrence at the original surgical site and at new sites. Clinical records and excisional biopsies from 106 equine sarcoids from 64 horses referred to Leahurst Equine Hospital, University of Liverpool, between March 2010 and February 2015 were ...
Immunogenicity analysis of BPV-1 positive equine sarcoid-derived cultured fibroblasts.
Veterinary immunology and immunopathology    January 4, 2023   Volume 256 110547 doi: 10.1016/j.vetimm.2023.110547
Gysens L, Depuydt E, Patruno M, Haspeslagh M, Spaas JH, Martens A.Sarcoids are the most common equine skin tumours Although they do not metastasize, they can be locally aggressive and cause significant clinical symptoms in affected horses. Despite being common, very little is known about the host immune response and the biological mechanisms underlying persistence and recurrence of equine sarcoids. The latter reflects the need for further research in this field. This in-vitro study used sarcoid explants from horses with naturally occurring sarcoids (n = 12) to evaluate the induction of a humoral immune response directed against equine sarcoid-derived bovin...
Management of equine sarcoids.
Veterinary journal (London, England : 1997)    November 2, 2022   Volume 291 105926 doi: 10.1016/j.tvjl.2022.105926
Hollis AR.Sarcoids are the most common cutaneous neoplasm of the horse, arising as a result of a neoplastic proliferation of fibroblasts associated with infection with bovine papillomavirus, most notably types 1 and 2. Although they do not metastasise, they are locally invasive and aggressive, and can lead to important welfare concerns, interfere with tack and therefore impede athleticism, and undoubtedly lead to a reduction in the value of affected horses. This review discusses the evidence behind the most commonly used treatments for equine sarcoids. The most commonly used treatments are discussed. No...
1 2 3 11